Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATIC | P31939 | 1/20 | 0.69 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.53 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.53 |
| ▸ | SENP3 | Q9H4L4 | 2/20 | 0.52 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.52 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2203513 | 1.00 | ATIC (0.69) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL29933125 | 1.00 | ATIC (0.69) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL31658970 | 1.00 | ATIC (0.69) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL11411897 | 0.98 | ATIC (0.67) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL9645286 | 0.87 | MEN1 (0.65) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL11511843 | 0.87 | LMNA (0.64) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL3083351 | 0.87 | MEN1 (0.65) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL11511844 | 0.87 | LMNA (0.64) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL29352135 | 0.87 | MEN1 (0.65) | ATICGLO1LMNAGAAHPGD | |
| SCHEMBL1309168 | 0.85 | L3MBTL1 (0.63) | ATICGLO1LMNAGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618726-A | DYE HAVING LIGNIN-LIKE SUBSTITUTION PATTERN AND A MICROBE CAPABLE OF PRODUCING EXTRACELLULAR PEROXIDASE | IDAHO RESEARCH FOUNDATION, INC. (US) | 1997-04-08 | — | — | US | claimed |
| JP-3041166-A | — | — | None | — | — | JP | disclosed |
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| US-7976781-B2 | Ozone detecting device | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20110154583-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2011-06-30 | — | — | US | disclosed |
| US-20100183480-A1 | OZONE DETECTING DEVICE | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| EP-2071328-A1 | OZONE-DETECTING ELEMENT | Nippon Telegraph and Telephone Corporation (JP) | 2009-06-17 | — | — | EP | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-5618726-A | DYE HAVING LIGNIN-LIKE SUBSTITUTION PATTERN AND A MICROBE CAPABLE OF PRODUCING EXTRACELLULAR PEROXIDASE | IDAHO RESEARCH FOUNDATION, INC. (US) | 1997-04-08 | — | — | US | disclosed |
| JP-H0341166-A | 4-((4-ALKOXY-1-NAPHTHYL)AZO)BENZENESULFONIC ACID, SALT THEREOF, AND SURFACE ACTIVE DYE | KAO CORP | 1991-02-21 | — | — | JP | disclosed |
| EP-0137177-B1 | CHROMOGENE AND FLUOROGENE CARBOXYLIC-ACID ESTERS, METHOD FOR THEIR PREPARATION AND AGENTS FOR THE DETECTION AND DETERMINATION OF HYDROLASES | BAYER AG (DE) | 1987-10-28 | — | — | EP | disclosed |
| EP-0137177-A1 | Chromogene and fluorogene carboxylic-acid esters, method for their preparation and agents for the detection and determination of hydrolases | BAYER AG (DE) | 1985-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110154583-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | ATIC 2651/4885GLO1 59/4885LMNA 316/4885 |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | ATIC 2651/4885GLO1 59/4885LMNA 316/4885 |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | ATIC 2651/4885GLO1 59/4885LMNA 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.